Vol. 45 | No. 2 | July-December 2017 Back

Open Access

Weathering an Adenosine-Insensitive Right Ventricular Outflow Tract Ventricular Tachycardia Storm in an Adolescent Female: A Case Report

Jose Eduardo DL. Duya, Nashiba Naud, Joerelle V. Mojica, Giselle G. Gervacio, Michael Joseph Agbayani, Louisa Go, Olympia Q. Malanyaon
Dec 2017 DOI 10.69944/pjc.46e2b0a132

Abstract

Majority of ventricular tachycardias (VT) are associated with structural disease. However, 10%  are idiopathic, such as right ventricular outflow tract (RVOT) VT. A vast majority of RVOT VT demonstrates sensitivity to adenosine, consistent with a triggered mechanism. We present the case of a 15-year-old female patient with palpitations, lightheadedness and dyspnea and a past history of a similar episode of incessant palpitations a month ago, which necessitated electrical cardioversion and amiodarone. On admission, a wide complex tachycardia was documented. Detailed analysis of her wide complex tachycardia showed left bundle branch block (LBBB) morphology, atrioventricular dissociation and positive QRS complexes in inferior leads, suggestive of RVOT VT storm. The patient’s arrhythmia was not responsive to adenosine; hence, adenosine-insensitive RVOT VT was considered. Synchronous cardioversion terminated the tachyarrhythmia. On electrophysiological studies, the VT was induced and localized at the RVOT via 3D-electroanatomical mapping. Radiofrequency ablation of the focus was performed, immediately terminating the tachycardia. The patient was discharged well. 

References
  1. Gard JJ, Asirvatham S. Outflow tract ventricular tachycardia. Tex Heart Inst J. 2012;39(4):526–528.
  2. Klabundle R. Adenosine. In: Cardiovascular Pharmacology Concepts. Available online at: http://cvpharmacology.com/antiarrhy/ adenosine.
  3. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016;67(13):e27-e115.
  4. Marill KA, Wolfram S, Desouza IS, Nishijima DK, Kay D, Setnik GS, et al. Adenosine for wide-complex tachycardia: efficacy and safety. Crit Care Med. 2009 Sep;37(9):2512-8.
  5. Reviriego SM, Merino JL. Ventricular Tachycardia in patients without apparent structural heart disease: Focus on Ventricular Outflow Tract Tachycardia. ESC Council for Cardiology Practice 2009;8(N°11 - 18 Nov 2009).
  6. Asirvatham SJ. Correlative anatomy for the invasive electrophysiologist: outflow tract and supravalvar arrhythmia. J Cardiovasc Electrophysiol 2009;20(8):955–68.
  7. Cheung JW, Ip JE, Yarlagadda RK, Liu CF, Thomas G, Xu L, et al. Adenosine-insensitive right ventricular tachycardia: novel variant of idiopathic outflow tract tachycardia. Heart Rhythm. 2014 Oct;11(10):1770-8.
  8. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48: e247–e346.
  9. Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. European Heart Rhythm Association / Heart Rhythm Society Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. Europace 2009;11:771–817.
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.